The median serum levels of anti-CD40 antibodies were significantly higher in the FSGS and MCD groups than in the controls and other glomerulopathies (membranous nephropathy, IgA nephropathy, and MPGN). This evidence concerns the gene CD40 and primary membranoproliferative glomerulonephritis.